Digital healthcare company BlinkLab (ASX:BB1) has tested the first patient in its US autism diagnostic study, which is geared at validating the company's Dx1 test as a diagnostic aid for clinicians.

Backers claim the tests can predict a child’s risk of autism using a strand of hair or a mother’s blood, but critics say they are not ready for the market.

April is Autism Acceptance Month — a time to raise awareness of autism, but also to promote acceptance, celebrate neurodiversity and individual differences, and advance inclusivity. Autism spectrum ...

Cerebellum (Latin for "little brain") in red. Source: Wikimedia/Life Sciences Database Neuroscientists at the University of Rochester have masterminded a rapid eye movement test that can detect ...